QA: Abbvie Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2015_Abbvie_Inc.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001551152, Abbvie Inc

  xvar xval
0 AssetsCurrent 16,088,000,000
1 IntangibleAssetsNetIncludingGoodwill 7,375,000,000
2 PropertyPlantAndEquipmentNet 2,485,000,000
3 remainder_Assets 1,599,000,000
4 LiabilitiesCurrent 11,400,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,724,000,000
9 ResearchAndDevelopmentExpense 3,649,000,000
10 remainder_Expenses 5,771,000,000
11 remainder_Revenues 19,960,000,000
12 remainder_NetIncome -1,042,000,000
13 remainder_ComprehensiveNetIncome -1,589,000,000
  yvar yval
0 Assets 27,547,000,000
1 Liabilities 11,400,000,000
2 Expenses 17,144,000,000
3 Revenues 19,960,000,000
4 StockholdersEquity 16,147,000,000
5 NetIncome 1,774,000,000
6 ComprehensiveNetIncome 979,500,000
7 BaseVar 39,341,000,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.86
9 EconomicCapitalRatio 2.93

Edgar->Model Mapping

Feature Distribution

Change over Time